Results of new cost-effectiveness study of different treatment strategies for gout presented at the American College of Rheumatology’s Annual Meeting in Atlanta, Georgia.
TiH researcher Celine van de Laar presented her findings on the cost-effectiveness of a JAK1/JAK2-inhibitor versus a biological DMARD in rheumatoid arthritis patients at the Annual European Congress of Rheumatology in Madrid, Spain.
Article about the development of the common metric for comparing the 10 most frequently used physical function PROMs in rheumatology published in Quality of Life Research.
International jury awards prestigious prize for our use of innovative technology to ease implementation of VBHC.
This week ICHOM released the standard set of outcomes for inflammatory arthritis. These outcomes are recommended for measuring and reporting the results of treatment that patients experience.
Article about the upcoming standard set published in the March issue of Medidact Reumatologie.
TiH has been nominated for the prestigious Value-Based Health Care Prize 2018 that recognizes inspiring VBHC initiatives.
Minister for Medical Care argues that we need to collect information about how patients experience the outcomes of care.
TiH researcher Celine van de Laar presents her poster at the 2017 ACR/ARHP Annual Meeting in San Diego, California.
We’re delighted to invite you to participate in the Open Review of the ICHOM Inflammatory Arthritis (IA) Standard Set.